Phoenix Controls, a Honeywell International business, today
announced the introduction of the Advanced Pressure Monitor II (APM2), a
device that monitors very low differential pressure between rooms. The
APM2 verifies directional airflow, and is used in critical ventilation
applications such as vivarium research, chemotherapy preparations,
hospital procedure rooms, and biocontainment facilities. The product is
available today.
“Pressure monitoring is a core part of our business because it verifies
that our valves are properly pressurizing the space”
Conceived with input from a wide range of users, the APM2 is designed to
meet the broad needs of laboratory, life sciences and healthcare
markets. For the architect, the device has a faceplate and touch-screen
that is attractive for use in the public spaces of modern facilities.
For the design engineer, the product performs functions that can meet
the specifications of virtually any room application. For the contractor
and installer, the unit is designed for easy rough-in, simple
installation and rapid commissioning. And for the end-user, the APM2
should provide years of continuous and reliable operation.
“Pressure monitoring is a core part of our business because it verifies
that our valves are properly pressurizing the space,” said Vincent
Schultz, general manager of Phoenix Controls. “The APM2 is also an
exciting visual product in the finished space, and this helps put
Phoenix Controls in front of new customers and brings us into new
markets.”
The APM2 blends two key functions together in a single unit; room
pressure monitoring and a bright touch-screen local display. The product
is a highly accurate pressure monitor, using true differential pressure
transducer technology. This means the APM2 can meet the most stringent
applications that require measurement of room pressure to 0.0001" WC
resolution, and with an accuracy of ±0.25% of full scale.
Osimertinib plus chemotherapy improves survival in EGFR-mutated lung cancer